The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 12, 2018

Filed:

Nov. 29, 2017
Applicant:

Taho Pharmaceuticals Ltd., Taipei, TW;

Inventors:

Chin Chung Lin, New Taipei, TW;

Chien-Chiao Wang, New Taipei, TW;

Catherine Lee, West Linn, OR (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/138 (2006.01); A61K 47/36 (2006.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 9/08 (2006.01); A61K 47/40 (2006.01);
U.S. Cl.
CPC ...
A61K 31/138 (2013.01); A61K 9/0053 (2013.01); A61K 9/08 (2013.01); A61K 47/10 (2013.01); A61K 47/36 (2013.01); A61K 47/40 (2013.01);
Abstract

Disclosed herein is an oral pharmaceutical composition in the form of an aqueous solution of atomoxetine as an active ingredient. The aqueous solution of atomoxetine comprises a taste-masked liquid carrier comprising peppermint, orange flavor and a viscosity agent. The combined flavors successfully masked atomoxetine hydrochloride's bitter smell and/or taste which makes it a novel palatable pharmaceutical composition. The viscosity agent improves the oral pharmaceutical composition's consistency and provides a smooth texture which makes it easy to swallow. More specifically, the oral pharmaceutical composition comprises effective amounts of: (a) atomoxetine or the pharmaceutically acceptable salts thereof; and (b) a taste-masked liquid carrier. Also provided is a method for making the aqueous solution of atomoxetine. The present disclosure also provides methods of using oral pharmaceutical composition for the treatment of a subject having a disorder treatable by the administration of atomoxetine. In one embodiment, the disorder is attention deficit hyperactivity disorder (ADHD).


Find Patent Forward Citations

Lin, Chin. (2018). Oral solution comprising atomoxetine hydrochloride and methods thereof (U.S. Patent No. 9993445). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9993445

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…